Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Advisory Panel Recommends Against Approval Of Novartis Heart Failure Drug
FDA Advisory Panel Recommends Against Approval Of Novartis Heart Failure Drug
FDA Advisory Panel Recommends Against Approval Of Novartis Heart Failure Drug
Submitted by
admin
on March 27, 2014 - 4:58pm
Source:
Forbes
News Tags:
FDA
Novartis
serelaxin
acute heart failure
advisory panels
Reasanz
Headline:
FDA Advisory Panel Recommends Against Approval Of Novartis Heart Failure Drug
Do Not Allow Advertisers to Use My Personal information
